BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 30406400)

  • 1. Silencing of RUNX2 enhances gemcitabine sensitivity of p53-deficient human pancreatic cancer AsPC-1 cells through the stimulation of TAp63-mediated cell death.
    Sugimoto H; Nakamura M; Yoda H; Hiraoka K; Shinohara K; Sang M; Fujiwara K; Shimozato O; Nagase H; Ozaki T
    Cell Death Dis; 2015 Oct; 6(10):e1914. PubMed ID: 26469963
    [No Abstract]   [Full Text] [Related]  

  • 2. BAP1 dependent expression of long non-coding RNA NEAT-1 contributes to sensitivity to gemcitabine in cholangiocarcinoma.
    Parasramka M; Yan IK; Wang X; Nguyen P; Matsuda A; Maji S; Foye C; Asmann Y; Patel T
    Mol Cancer; 2017 Jan; 16(1):22. PubMed ID: 28122578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA HOST2 promotes NSUN2-mediated breast cancer progression via interaction with ELAVL1.
    Wang X; Liu D; Hua K; Fang L
    Cell Signal; 2024 May; 117():111112. PubMed ID: 38387687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noncoding RNAs: an emerging modulator of drug resistance in pancreatic cancer.
    Wei L; Sun J; Wang X; Huang Y; Huang L; Han L; Zheng Y; Xu Y; Zhang N; Yang M
    Front Cell Dev Biol; 2023; 11():1226639. PubMed ID: 37560164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D1018 with higher stability and excellent lipopolysaccharide binding affinity has potent anti-bacterial and anti-inflammatory activity.
    Wu R; Dong X; Wang Q; Zhang Z; Wang J; Wang X
    Front Microbiol; 2022; 13():1010017. PubMed ID: 36532445
    [No Abstract]   [Full Text] [Related]  

  • 6. Research updates on the clinical implication of long noncoding RNA in digestive system cancers and chemoresistance.
    Miao X; Wang F; Wang T; Razak SRA; Yunus MA; Ismail IS
    3 Biotech; 2021 Sep; 11(9):423. PubMed ID: 34603923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNAs: role and contribution in pancreatic cancer.
    Ramya Devi KT; Karthik D; Mahendran T; Jaganathan MK; Hemdev SP
    Transcription; 2021 Feb; 12(1):12-27. PubMed ID: 34036896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA PCDH10 regulates the tumorigenesis of pancreatic cancer through the miR-338-3p/hTERT axis.
    Zhang S; Qiu M; Gao S; Tian T
    Am J Transl Res; 2021; 13(4):2181-2197. PubMed ID: 34017382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non‑coding RNA‑DUXAP8 regulates TOP2A in the growth and metastasis of osteosarcoma via microRNA‑635.
    Yang T; Guo JP; Li F; Xiu C; Wang H; Duan XL
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33982765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of a novel antimicrobial peptide 1018M targeted ppGpp to inhibit MRSA biofilm formation.
    Jiale Z; Jian J; Xinyi T; Haoji X; Xueqin H; Xiao W
    AMB Express; 2021 Mar; 11(1):49. PubMed ID: 33770266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Ivermectin-Derived Compound D4 and Its Antimicrobial/Biofilm Properties against MRSA.
    Tan X; Xie H; Zhang B; Zhou J; Dou Z; Wang X; Wang N
    Antibiotics (Basel); 2021 Feb; 10(2):. PubMed ID: 33672669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of taurine, its haloamines and its lncRNA TUG1 in both inflammation and cancer progression. On the road to therapeutics? (Review).
    Baliou S; Kyriakopoulos AM; Spandidos DA; Zoumpourlis V
    Int J Oncol; 2020 Sep; 57(3):631-664. PubMed ID: 32705269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The multifaceted roles of long noncoding RNAs in pancreatic cancer: an update on what we know.
    Zhou W; Chen L; Li C; Huang R; Guo M; Ning S; Ji J; Guo X; Lou G; Jia X; Zhao J; Luo F; Li C; Qu Z; Yu S; Tai S
    Cancer Cell Int; 2020; 20():41. PubMed ID: 32042268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenomics of Pancreatic Cancer: A Critical Role for Epigenome-Wide Studies.
    Singh RR; Reindl KM; Jansen RJ
    Epigenomes; 2019 Mar; 3(1):. PubMed ID: 31772762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel discoveries targeting gemcitabine-based chemoresistance and new therapies in pancreatic cancer: How far are we from the destination?
    Luo W; Yang G; Qiu J; Luan J; Zhang Y; You L; Feng M; Zhao F; Liu Y; Cao Z; Zheng L; Zhang T; Zhao Y
    Cancer Med; 2019 Oct; 8(14):6403-6413. PubMed ID: 31475468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Long Noncoding RNA HOST2 Promotes Gemcitabine Resistance in Human Pancreatic Cancer Cells.
    An N; Cheng D
    Pathol Oncol Res; 2020 Jan; 26(1):425-431. PubMed ID: 30406400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA SNHG8 promotes the development and chemo-resistance of pancreatic adenocarcinoma.
    Song Y; Zou L; Li J; Shen ZP; Cai YL; Wu XD
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8161-8168. PubMed ID: 30556854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of LncRNA-HOST2 on cell proliferation, migration, invasion and apoptosis of human hepatocellular carcinoma cell line SMMC-7721.
    Liu RT; Cao JL; Yan CQ; Wang Y; An CJ; Lv HT
    Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28143959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo.
    Cao J; Yang J; Ramachandran V; Arumugam T; Deng D; Li Z; Xu L; Logsdon CD
    PLoS One; 2015; 10(12):e0144969. PubMed ID: 26709920
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.